Data presented at aacr 2023 highlights exscientia's clinical and preclinical development

Oxford, england--(business wire)--exscientia plc (nasdaq: exai) today announced four presentations at the american association for cancer research (aacr) annual meeting 2023, being held from april 14-19, 2023 in orlando, fl. “we're excited to further validate exscientia's end-to-end approach of integrating outstanding science with cutting-edge ai-driven precision medicine and translational research capabilities,” said andrew hopkins, d.phil, founder and chief executive officer of exscientia.
EXAI Ratings Summary
EXAI Quant Ranking